Trileptal and Dyslipidaemia - a phase IV clinical study of FDA data

Summary:

Dyslipidaemia is reported as a side effect among people who take Trileptal (oxcarbazepine), especially for people who are male, 30-39 old, have been taking the drug for 1 - 2 years also take Seroquel, and have Schizophrenia.

The phase IV clinical study analyzes which people have Dyslipidaemia when taking Trileptal. It is created by eHealthMe based on reports of 22,012 people who have side effects when taking Trileptal from the FDA, and is updated regularly.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 836 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

22,012 people reported to have side effects when taking Trileptal.
Among them, 15 people (0.07%) have Dyslipidaemia.

Among these 15 people:

How long have people been on Trileptal when they have Dyslipidaemia? *

What is the gender of people who have Dyslipidaemia when taking Trileptal? *

female: 40 %
male: 60 %

What is the age of people who have Dyslipidaemia when taking Trileptal? *

What are other drugs people take besides Trileptal? *

What are other side effects people have besides Dyslipidaemia? *

Type 2 Diabetes: 8 people, 53.33%
Chest Pain: 8 people, 53.33%
Neuropathy Peripheral (surface nerve damage): 7 people, 46.67%
Impaired Fasting Glucose: 6 people, 40.00%
Hypertriglyceridaemia (excess of triglycerides in the blood): 6 people, 40.00%
Pneumonia: 6 people, 40.00%
Hepatitis C: 6 people, 40.00%
Diabetic Foot: 6 people, 40.00%
Diabetes With Hyperosmolarity (diabetes with increasing blood glucose levels and dehydration): 6 people, 40.00%
Abdominal Pain Upper: 6 people, 40.00%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 40.00%
Affective Disorder (mental disorder): 4 people, 26.67%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 20.00%
Depression: 3 people, 20.00%
Sleep Disorder: 2 people, 13.33%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 13.33%
Joint Pain: 2 people, 13.33%
Insomnia (sleeplessness): 2 people, 13.33%
Diabetes: 1 person, 6.67%
Bladder Spasm: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and have Dyslipidaemia?

- Check whether Dyslipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trileptal:

Trileptal (23,558 reports)

Dyslipidaemia treatments and more:

Dyslipidaemia (42,009 reports)

Browse all side effects of Trileptal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyslipidaemia:

Dyslipidaemia (836 drugs)

Browse all the conditions that are associated with Dyslipidaemia:

Dyslipidaemia (711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Trileptal) and Trileptal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.